You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tl-895

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

Active, not recruiting
  • Relapsed/Refractory B Cell Malignancies
  • +3 more
  • TL-895
  • Columbus, Ohio
  • +17 more
Aug 18, 2022

COVID-19, Sars-CoV2, Cancer Trial in Augusta, Columbus (TL-895)

Completed
  • COVID-19
  • +5 more
  • TL-895
  • Augusta, Georgia
  • +1 more
May 10, 2021

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • TL-895
  • Aurora, Colorado
  • +65 more
Jun 2, 2022